BioLife Solutions Inc (BLFS)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 48.91% | 39.51% | 24.29% | 24.69% | 25.26% | 6.44% | 21.42% | -18.90% | -17.58% | 5.54% | 2.68% | 51.90% | 52.63% | 66.76% | 65.04% | 55.83% | 48.59% | -19.13% | -10.48% | 2.50% |
| Operating profit margin | -12.73% | -22.47% | -33.05% | -36.07% | -37.02% | -57.78% | -52.81% | -93.06% | -90.38% | -74.28% | -77.38% | -30.50% | -29.59% | -22.89% | -16.46% | -14.39% | -12.98% | -3.86% | -3.05% | -1.24% |
| Pretax margin | -19.68% | -37.40% | -58.29% | -45.84% | -46.40% | -66.30% | -52.04% | -92.60% | -89.94% | -73.72% | -73.12% | -26.00% | -24.43% | -17.37% | -17.56% | -46.82% | -2.66% | 15.12% | 48.10% | 113.94% |
| Net profit margin | -19.62% | -37.43% | -58.42% | -45.97% | -46.52% | -66.38% | -51.68% | -89.93% | -86.82% | -68.86% | -65.05% | -11.01% | -7.50% | 4.17% | 3.80% | -40.63% | 4.12% | 18.86% | 52.30% | 118.52% |
BioLife Solutions Inc has shown varying levels of profitability over the years based on its profitability ratios.
1. Gross Profit Margin: The company experienced fluctuations in its gross profit margin, starting with negative figures in mid-2020 and gradually improving to reach levels above 40% by the end of 2024, indicating an overall positive trend.
2. Operating Profit Margin: Similarly, the operating profit margin was negative in the initial periods but showed signs of improvement over time, with the margin moving towards less negative values by the end of 2024.
3. Pretax Margin: The pretax margin displays a similar pattern of improvement, with the company gradually reducing its losses over the years, although it remained negative by the end of 2024.
4. Net Profit Margin: The net profit margin, representing the company's bottom line, also depicts a trend of loss reduction, but profitability levels remained negative throughout the period under review, indicating ongoing challenges in generating net income.
In summary, BioLife Solutions Inc has made progress in improving its profitability ratios over the years, as seen in the positive trends in gross and operating profit margins. However, the company continues to face challenges in achieving sustained profitability, as evidenced by the consistent negative net profit margins.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -3.28% | -7.24% | -11.08% | -12.30% | -12.81% | -21.64% | -19.68% | -33.86% | -32.33% | -23.51% | -24.25% | -7.74% | -6.34% | -3.95% | -2.34% | -3.16% | -2.66% | -0.81% | -0.98% | -0.44% |
| Return on assets (ROA) | -5.05% | -12.06% | -19.59% | -15.67% | -16.10% | -24.87% | -19.26% | -32.72% | -31.05% | -21.79% | -20.39% | -2.79% | -1.61% | 0.72% | 0.54% | -8.93% | 0.84% | 3.97% | 16.83% | 41.91% |
| Return on total capital | -3.70% | -8.29% | -16.53% | -19.29% | -19.94% | -30.30% | -23.93% | -39.60% | -37.51% | -26.72% | -27.46% | -8.74% | -7.26% | -4.46% | -2.64% | -11.40% | -0.30% | 3.34% | 16.67% | 56.53% |
| Return on equity (ROE) | -5.78% | -14.14% | -22.85% | -18.88% | -19.67% | -30.79% | -23.69% | -40.80% | -38.39% | -26.25% | -23.43% | -3.20% | -1.86% | 0.82% | 0.62% | -10.27% | 0.97% | 4.16% | 18.12% | 58.80% |
BioLife Solutions Inc's profitability ratios have shown a declining trend over the past few years.
- Operating return on assets (Operating ROA) has decreased from -0.44% in March 2020 to -3.28% in December 2024, indicating the company's declining ability to generate profit from its assets.
- Return on assets (ROA) declined from 41.91% in March 2020 to -5.05% in December 2024, suggesting a decrease in the company's ability to generate profit relative to its total assets.
- Return on total capital also showed a decreasing trend, from 56.53% in March 2020 to -3.70% in December 2024, reflecting a diminishing return on the capital invested in the business.
- Return on equity (ROE) dropped from 58.80% in March 2020 to -5.78% in December 2024, indicating a decline in the company's ability to generate profit for its shareholders.
Overall, these declining profitability ratios suggest that BioLife Solutions Inc's profitability has weakened over the years, raising concerns about the company's ability to generate returns for its assets, total capital, and equity investors.